By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Practice > Clinical Updates > Nearly half of Americans now cost-insecure for healthcare, hitting 5-year low
Clinical UpdatesHealth PolicyPolicy & SystemsPractice

Nearly half of Americans now cost-insecure for healthcare, hitting 5-year low

GMJ
Last updated: 09/07/2026 15:51
By
GMJ Practice Desk
Share
7 Min Read
Chart showing declining healthcare cost security in the United States from 2021 to 2026Illustrative image · Photo by Anastasiia Gudantova on Unsplash (Unsplash License)
A new West Health-Gallup Center survey finds that just 49% of Americans can consistently afford healthcare and medications—the lowest level since 2021. The declining affordability index signals a deepening crisis in medical access across the nation. — Photo by Anastasiia Gudantova on Unsplash (Unsplash License)
SHARE
🎧 Listen to this article6:20 min · 922 words · GMJ Audio
5 min read|922 words
✓ Reviewed by GMJ News Editorial Team

🟠 Moderate Evidence

Contents
    • Key takeaways
      • Study at a Glance
      • US Healthcare Cost Security Declining Since 2021
  • Widening gap in medical affordability
  • Economic drivers and vulnerable populations
  • Policy and systemic implications
    • What this means
  • Frequently asked questions
    • What does “Cost Secure” mean?
    • Why is affordability declining despite insurance coverage expansion?
    • What policy changes could improve affordability?

Fewer than half of Americans—49%—can reliably afford healthcare and prescription medications when needed, according to the West Health-Gallup Center on Healthcare in America. This represents the lowest affordability level since the Healthcare Affordability Index launched in 2021, signalling a deepening crisis in medical access across the United States.

Key takeaways

  • 49% of Americans are “Cost Secure”—able to consistently afford healthcare and medications—the lowest since 2021
  • The majority of the US population now faces financial barriers to essential medical care
  • Findings suggest urgent policy and healthcare system reforms needed to restore affordability

Study at a Glance

Source West Health-Gallup Center on Healthcare in America
Study type Population survey / Healthcare Affordability Index
Population US adults
Metric “Cost Secure” status (ability to afford healthcare and medications)
Time period 2021–2026
49%
of Americans classified as “Cost Secure” according to the West Health-Gallup Center Healthcare Affordability Index (2026)—the lowest level since the index began tracking affordability in 2021

US Healthcare Cost Security Declining Since 2021

Percentage of Americans “Cost Secure” (able to afford healthcare and medications consistently), West Health-Gallup Center, 2021–2026

49%
2026 (current)
53%
2021 (baseline)
4 pp decline
2021–2026

Source: West Health-Gallup Center on Healthcare in America, 2026 | Georgian Medical Journal News

Submit Your Paper
GMJ_Submit_Banner

Widening gap in medical affordability

The West Health-Gallup Center’s findings reveal that a majority of the American population now faces financial barriers when accessing necessary medical care. Being “Cost Secure,” as defined by the survey, means individuals can consistently pay for healthcare visits and prescription medications without financial hardship—a threshold that fewer than half of US adults now meet.

🎙️ Related Podcast Episodes
🎧 #25 | WHO Warns: Childhood Hearing Loss Must Be Addressed Early · 19m
🎧 #15 | WHO: One in Two People Facing Cataract Blindness Still Need Access to Surgery · 21m

The steady decline from 53% in 2021 to 49% in 2026 suggests systemic pressures on healthcare affordability are intensifying. This metric serves as a key indicator of population health system performance and has direct implications for medication adherence, preventive care utilization, and chronic disease management across the nation.

Economic drivers and vulnerable populations

While the West Health-Gallup Center survey does not provide detailed breakdowns by demographic group in the source summary, research from the Kaiser Family Foundation has consistently shown that healthcare affordability crises disproportionately affect low-income households, racial and ethnic minorities, and individuals with chronic conditions. The timing of the West Health-Gallup findings—during a period of inflation and rising prescription drug costs—suggests multiple economic factors may be contributing to the deterioration.

Cost-related barriers to care include delayed or skipped medical visits, non-adherence to prescribed medications, and rationing of essential treatments. These gaps in access are known to worsen health outcomes and increase downstream emergency care utilization, creating a cycle that ultimately costs the healthcare system more.

Policy and systemic implications

The Healthcare Affordability Index represents an attempt to move beyond traditional insurance coverage metrics and measure actual out-of-pocket financial burden on patients. The index’s decline to a 5-year low underscores that health policy and reform strategies focused solely on insurance enrollment rates may miss the broader affordability crisis facing insured and uninsured populations alike.

Policy responses being discussed include price transparency initiatives, drug pricing reform, and expanded subsidies for prescription medications and out-of-pocket costs. The Centers for Medicare & Medicaid Services (CMS) and Congress have begun exploring measures to cap patient cost-sharing and negotiate drug prices, though implementation timelines remain uncertain.

Fewer than half of Americans (49%) are now “Cost Secure,” meaning they can consistently afford healthcare and prescription medications when needed—the lowest level recorded since the Healthcare Affordability Index launched in 2021.

— West Health-Gallup Center on Healthcare in America (2026)

What this means

For patients: Individuals and families should be aware that cost-related barriers to care—including medication delays, skipped doses, and deferred visits—are now experienced by a majority. Exploring patient assistance programs, generic alternatives, and community health resources may help mitigate financial hardship.
For clinicians: Providers should routinely assess patients’ ability to afford prescribed treatments and medications during clinical encounters. Discussions about cost-effective alternatives, sample programs, and referrals to social services can help prevent medication non-adherence driven by financial constraints.
For policymakers: The declining affordability index signals urgent need for systemic healthcare reform, including drug pricing controls, out-of-pocket cost caps, and enhanced subsidies for vulnerable populations. Current policy responses may be insufficient to reverse the affordability trend.

Frequently asked questions

What does “Cost Secure” mean?

According to the West Health-Gallup Center, “Cost Secure” refers to individuals who can consistently afford healthcare services and prescription medications when and where they need them, without experiencing financial hardship. The inverse—cost insecurity—means individuals face barriers, delays, or choices between purchasing medications and other necessities.

Why is affordability declining despite insurance coverage expansion?

Insurance coverage and actual affordability are distinct measures. Even insured individuals face rising deductibles, copayments, and coinsurance, as well as out-of-network costs. Rising prescription drug prices and medical service inflation have outpaced insurance benefit improvements, leaving many patients with unmanageable out-of-pocket expenses.

What policy changes could improve affordability?

Proposed reforms include federal price negotiation for prescription drugs (as authorized by recent legislation), caps on annual out-of-pocket maximums, expanded insurance subsidies, and transparency requirements for healthcare pricing. Clinical and policy communities continue to debate the most effective combination of interventions.

As healthcare costs continue to rise faster than wage growth and inflation, the affordability crisis threatens to deepen unless policymakers implement sustained, evidence-based reforms. The West Health-Gallup Center’s index provides critical data for tracking progress—or continued deterioration—in population access to essential care. Continued monitoring of this metric, paired with granular analysis of which populations face the steepest barriers, will be essential for targeting interventions effectively.

Source: Americans’ ability to afford health care falls to 5-year low — West Health-Gallup Center on Healthcare in America (2026)

Was this article helpful?

Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →

Related Coverage

UK's MHRA Launches Innovation Guidance to Accelerate Medical Device and Drug DevelopmentAug 10, 2026
Rural Healthcare's $50 Billion Question: Can Technology Alone Solve Workforce Shortages?Aug 10, 2026
FDA-Approved Drug Restores Immunotherapy Efficacy in Rare Liver Cancer by Releasing Trapped T CellsAug 10, 2026
Timing of Second Stent Placement After Heart Attack: New Trial Challenges Immediate Intervention StrategyAug 10, 2026
🔥 Most read this week
1Why High-Dose Vitamin B12 Supplements Work Despite Poor Absorption
2Creatine Kidney Damage Myth Debunked by Major Safety Review of 26,000 Participants
3Magnesium Form May Not Matter for Cognitive Benefits, New Meta-Analysis Suggests
4Magnesium Supplements: Marketing Claims vs Scientific Evidence
PG
Editorial oversight
Prof. Giorgi Pkhakadze, MD, MPH, PhD
Editor-in-Chief, GMJ News
Full profile →  ·  ORCID 0000-0001-7609-4515
Medical disclaimer. This article is health journalism intended for general information. It is not medical advice and is not a substitute for consultation with a qualified healthcare professional. Always seek your physician's advice regarding any medical condition.
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
📬 GMJ Health Digest
Evidence-based medical news, once a week. Free, no spam, unsubscribe anytime.
TAGGED:cost securityhealth policyhealthcare affordabilityprescription drug costsUnited States healthcare
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByGMJ Practice Desk
Follow:
GMJ Practice Desk is part of GMJ News, the newsroom of the Georgian Medical Journal (gmj.ge), published by the Public Health Institute of Georgia. Every article is editorially reviewed before publication.
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK’s MHRA Launches Innovation Guidance to Accelerate Medical Device and Drug Development

The UK's MHRA has published formal guidance for drug and medical device…

Rural Healthcare’s $50 Billion Question: Can Technology Alone Solve Workforce Shortages?

A $50 billion US rural healthcare investment prioritises technology infrastructure, but health…

FDA-Approved Drug Restores Immunotherapy Efficacy in Rare Liver Cancer by Releasing Trapped T Cells

Researchers have identified that rare liver cancers evade immunotherapy by trapping immune…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

UK pharmaceutical manufacturing facility with MHRA regulatory approval documentationPhoto by Pilan Filmes on Pexels (Pexels License)
Health PolicyPolicy & Systems

UK Approves 47 New Pharmaceutical Manufacturing and Wholesale Dealer Licences in Latest MHRA Review

By
GMJ Policy Desk
12/06/2026
Wegovy oral tablets and injectable pens showing new UK-approved weight loss treatment optionsIllustrative image · Photo by www.kaboompics.com on Pexels (Pexels License)
Clinical UpdatesHealth PolicyPolicy & SystemsPractice

UK Approves First Oral GLP-1 Pill for Weight Loss as Wegovy Tablet Gets MHRA Clearance

By
GMJ Practice Desk
28/06/2026
Evidence review infographic showing health behaviour timing windows: caffeine 150 minutes post-waking, exercise 4 hours pre-sleep, potassium-sodium ratios for blood pressure.Illustrative image · Photo by cottonbro studio on Pexels (Pexels License)
Clinical UpdatesData & NumbersNew StudiesPracticeResearch Digest

Evidence Review: Five Health Behaviours Reshaping 2025 Clinical Practice

By
GMJ Practice Desk
29/07/2026
Infographic showing global blood donation statistics and safety improvements by WHOIllustrative image · Photo by Nguyễn Hiệp on Unsplash (Unsplash License)
Global HealthPolicy & Systems

Global blood safety improves but access gaps persist as WHO reports 85% voluntary donations

By
GMJ Policy Desk
28/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up